Trials / Completed
CompletedNCT00596037
Treatment of Adults With Growth Hormone Deficiency
A Phase III, Open-label, Uncontrolled, Multicentre, Rollover Study to Assess Safety and Efficacy of LB03002 Administered Weekly in Adults With Growth Hormone Deficiency
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 136 (actual)
- Sponsor
- LG Life Sciences · Industry
- Sex
- All
- Age
- 23 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this rollover study is to evaluate the long term (1 year) safety of a new weekly administered growth hormone preparation in adults with growth hormone deficiency who were treated with the same experimental preparation in study BPLG-005. In addition, further change in efficacy endpoints of BPLG-005 by prolonged treatment will be evaluated. Additional efficacy and safety data of the experimental preparation will be obtained from the switch-over patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Growth hormone - LB03002 |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-09-01
- Completion
- 2009-05-01
- First posted
- 2008-01-16
- Last updated
- 2012-10-05
Source: ClinicalTrials.gov record NCT00596037. Inclusion in this directory is not an endorsement.